2016
DOI: 10.1007/s00210-016-1328-1
|View full text |Cite
|
Sign up to set email alerts
|

cUMP hydrolysis by PDE3A

Abstract: As previously reported, the cardiac phosphodiesterase PDE3A hydrolyzes cUMP. Moreover, cUMP-degrading activity was detected in cow and dog hearts several decades ago. Our aim was to characterize the enzyme kinetic parameters of PDE3A-mediated cUMP hydrolysis and to investigate whether cUMP and cUMP-hydrolyzing PDEs are present in cardiomyocytes. PDE3A-mediated cUMP hydrolysis was characterized in time course, inhibitor, and Michaelis-Menten kinetics experiments. Intracellular cyclic nucleotide (cNMP) concentra… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 37 publications
0
2
0
Order By: Relevance
“…The cyclic nucleotide phosphodiesterase, PDE3A, is well-characterized with regard to its ability to hydrolyze the phosphodiester bonds of cAMP and cGMP to regulate and limit cellular responses to G protein-coupled receptor activation (3). More recently, evidence has also arisen for a role in hydrolysis of cUMP (4). Conversely, very little is known regarding SLFN12 function, although it may play a role in cell proliferation or differentiation (5)(6)(7)(8).…”
mentioning
confidence: 99%
“…The cyclic nucleotide phosphodiesterase, PDE3A, is well-characterized with regard to its ability to hydrolyze the phosphodiester bonds of cAMP and cGMP to regulate and limit cellular responses to G protein-coupled receptor activation (3). More recently, evidence has also arisen for a role in hydrolysis of cUMP (4). Conversely, very little is known regarding SLFN12 function, although it may play a role in cell proliferation or differentiation (5)(6)(7)(8).…”
mentioning
confidence: 99%
“…Moreover, the pyrimidine nucleoside uridine activates adenosine receptors (Yilmaz et al 2008). Thus, the non-canonical cyclic nucleotide cUMP, which is currently discussed as a potential second messenger (Seifert et al 2015;Berrisch et al 2017;Ostermeyer et al 2018;Scharrenbroich et al 2019), may as well be exported and degraded to biologically active products. Preliminary results suggest that first-and second messenger effects of cyclic nucleotides are highly dependent on the investigated cell type (Schneider et al 2015).…”
Section: Introductionmentioning
confidence: 99%